David E. Kang

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

Sascha Weggen, Jason L. Eriksen, Pritam Das et al. · Nature · 2001 · 1.4K citations

Life Sciences, Neuroscience, Pharmacology +14

Genetic evidence for the involvement of τ in progressive supranuclear palsy

Chris Conrad, Athena Andreadis, John Q. Trojanowski et al. · Annals of Neurology · 1997 · 390 citations

Life Sciences, Genetics, Neurology +14

Modulation of amyloid β-protein clearance and Alzheimer’s disease susceptibility by the LDL receptor–related protein pathway

David E. Kang, Claus U. Pietrzik, Larry Baum et al. · Journal of Clinical Investigation · 2000 · 354 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell Carcinoma

David E. Kang, Richard L. White, James H. Zuger et al. · The Journal of Urology · 2004 · 307 citations

Medicine, Nuclear Medicine, Radiology +17

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease

David E. Kang, T Saitoh, X. Chen et al. · Neurology · 1997 · 298 citations

Medicine, Genetics, Molecular Genetics +17